Named on 7 rounds in the feed, most often at Seed and in AI.
Rounds from 2023-10-26 to 2026-09-23
ROUNDS
7
led 3, joined 4
LED ROUNDS · USD
$390M
across 3 rounds · 3 co-led, split evenly
CO-INVESTORS
61
most often with Andreessen Horowitz
Named on 7 rounds in the feed, most often at Seed and in AI.
Rounds from 2023-10-26 to 2026-09-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Tekever An autonomous systems developer | Series D Verified against 4 of 52 sources | $580M | 2026-09-23 | [ LEAD ] |
OpenAI OpenAI provides advanced AI research and tools for developers and businesses looking to integrate AI technologies. | Funding round Verified against 4 of 10 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $122B | 2026-03-31 | [ PART ] |
Arena AI Lmarena offers AI-driven tools for creating web applications, including landing pages, dashboards, games, and online stores. | Seed Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-05-21 | [ LEAD ] |
Arena AI model evaluator | Seed Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-05-21 | [ LEAD ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Funding round Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2025-04-03 | [ PART ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Seed Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2024-02-08 | [ PART ] |
Abridge Abridge sells an AI-powered clinical documentation platform for healthcare professionals, enhancing the accuracy and efficiency of patient interactions and documentation. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2023-10-26 | [ PART ] |